Gainers

• Polyrizon (NASDAQ:PLRZ) shares rose 11.3% to $14.61 during Thursday's after-market session. The market value of their outstanding shares is at $14.6 million.
• ENDRA Life Sciences (NASDAQ:NDRA) stock rose 5.26% to $4.2. The company's market cap stands at $5.3 million.
• Eledon Pharmaceuticals (NASDAQ:ELDN) shares moved upwards by 3.97% to $2.24. The company's market cap stands at $159.8 million.
• High Tide (NASDAQ:HITI) shares rose 3.29% to $2.51. The company's market cap stands at $216.0 million. As per the news, the Q4 earnings report came out today.
• Mereo BioPharma Group (NASDAQ:MREO) stock moved upwards by 2.93% to $0.45. The market value of their outstanding shares is at $71.4 million.
• Streamex (NASDAQ:STEX) stock rose 2.87% to $3.44. The company's market cap stands at $314.4 million.

Losers

• Anbio Biotechnology (NASDAQ:NNNN) stock decreased by 10.9% to $22.93 during Thursday's after-market session. The company's market cap stands at $846.6 million.
• Healthcare Triangle (NASDAQ:HCTI) stock fell 8.16% to $0.28. The company's market cap stands at $3.2 million.
• Adlai Nortye (NASDAQ:ANL) stock decreased by 8.12% to $6.0. The market value of their outstanding shares is at $128.0 million.
• OSR Holdings (NASDAQ:OSRH) stock decreased by 5.4% to $0.61. The market value of their outstanding shares is at $15.9 million.
• Quince Therapeutics (NASDAQ:QNCX) stock decreased by 5.15% to $0.26. The market value of their outstanding shares is at $177.0 million.
• AlphaTON Capital (NASDAQ:ATON) stock fell 3.6% to $0.71. The market value of their outstanding shares is at $8.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.